» Articles » PMID: 37540718

High-throughput Screening Identifies Cell Cycle-associated Signaling Cascades That Regulate a Multienzyme Glucosome Assembly in Human Cells

Overview
Journal PLoS One
Date 2023 Aug 4
PMID 37540718
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously demonstrated that human liver-type phosphofructokinase 1 (PFK1) recruits other rate-determining enzymes in glucose metabolism to organize multienzyme metabolic assemblies, termed glucosomes, in human cells. However, it has remained largely elusive how glucosomes are reversibly assembled and disassembled to functionally regulate glucose metabolism and thus contribute to human cell biology. We developed a high-content quantitative high-throughput screening (qHTS) assay to identify regulatory mechanisms that control PFK1-mediated glucosome assemblies from stably transfected HeLa Tet-On cells. Initial qHTS with a library of pharmacologically active compounds directed following efforts to kinase-inhibitor enriched collections. Consequently, three compounds that were known to inhibit cyclin-dependent kinase 2, ribosomal protein S6 kinase and Aurora kinase A, respectively, were identified and further validated under high-resolution fluorescence single-cell microscopy. Subsequent knockdown studies using small-hairpin RNAs further confirmed an active role of Aurora kinase A on the formation of PFK1 assemblies in HeLa cells. Importantly, all the identified protein kinases here have been investigated as key signaling nodes of one specific cascade that controls cell cycle progression in human cells. Collectively, our qHTS approaches unravel a cell cycle-associated signaling network that regulates the formation of PFK1-mediated glucosome assembly in human cells.

Citing Articles

Mechanistic insights into condensate formation of human liver-type phosphofructokinase by stochastic modeling approaches.

Kang H, Nguyen L, An S, Kyoung M Sci Rep. 2024; 14(1):19011.

PMID: 39152221 PMC: 11329711. DOI: 10.1038/s41598-024-69534-w.


Hypoxia-inducible factor-driven glycolytic adaptations in host-microbe interactions.

DeMichele E, Buret A, Taylor C Pflugers Arch. 2024; 476(9):1353-1368.

PMID: 38570355 PMC: 11310250. DOI: 10.1007/s00424-024-02953-w.


Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1.

Campos M, Albrecht L Cancers (Basel). 2024; 16(1).

PMID: 38201444 PMC: 10778546. DOI: 10.3390/cancers16010016.


Size-Specific Modulation of a Multienzyme Glucosome Assembly during the Cell Cycle.

Jeon M, Schmitt D, Kyoung M, An S ACS Bio Med Chem Au. 2023; 3(5):461-470.

PMID: 37876499 PMC: 10591302. DOI: 10.1021/acsbiomedchemau.3c00037.

References
1.
Strang B . RO0504985 is an inhibitor of CMGC kinase proteins and has anti-human cytomegalovirus activity. Antiviral Res. 2017; 144:21-26. PMC: 9233920. DOI: 10.1016/j.antiviral.2017.05.004. View

2.
Drewry D, Wells C, Andrews D, Angell R, Al-Ali H, Axtman A . Progress towards a public chemogenomic set for protein kinases and a call for contributions. PLoS One. 2017; 12(8):e0181585. PMC: 5540273. DOI: 10.1371/journal.pone.0181585. View

3.
Mathews Griner L, Guha R, Shinn P, Young R, Keller J, Liu D . High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A. 2014; 111(6):2349-54. PMC: 3926026. DOI: 10.1073/pnas.1311846111. View

4.
Icard P, Fournel L, Wu Z, Alifano M, Lincet H . Interconnection between Metabolism and Cell Cycle in Cancer. Trends Biochem Sci. 2019; 44(6):490-501. DOI: 10.1016/j.tibs.2018.12.007. View

5.
Zacharias D, Violin J, Newton A, Tsien R . Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 2002; 296(5569):913-6. DOI: 10.1126/science.1068539. View